Ascend Capital’s Veracyte VCYT Stock Holding History

Ascend Capital’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-123,276	Closed	-$1.08M	–	248
2017 Q3	$1.08M	Buy	+123,276	New	+$1M	0.04%	148

Other funds holding VCYT

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ascend Capital's VCYT Position: Q4 2017 in Review

Ascend Capital sold out of Veracyte (VCYT) in Q4 2017, closing a stake of 123,276 shares — an estimated $1.08M sold.

Ascend Capital first reported a position in VCYT in Q3 2017 and held it in 1 quarter. The position peaked at $1.08M in Q3 2017. 79 funds tracked by Wall St. Rank hold VCYT as of Q4 2017.

Ascend Capital reported no remaining Veracyte position as of Q4 2017 after selling out during the quarter.
Ascend Capital sold 123,276 Veracyte shares in Q4 2017, an estimated $1.08M.
Ascend Capital first reported a position in Veracyte in Q3 2017 and held it in 1 quarter.
Ascend Capital's Veracyte position peaked at $1.08M in Q3 2017.
79 funds tracked by Wall St. Rank held Veracyte as of Q4 2017.

Based on Ascend Capital's 13F filing for Q4 2017, filed 13 Feb 2018.